Study title: Effect of longer-term (4 month) treatment with cimetidine on the clinical status of children with cystic fibrosis
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Digestive System Diseases [C06] | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report, Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: CIMETIDINE | |||||
| ATC code: | |||||
| Document link: Study 334-E-SUI-03-02-GI-D451-Cimetidine_DR Approved.xls | |||||
| Document date: 2011-09-07 | |||||
| Study number: 334/E/SUI/03/02/GI Long Term | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |